Kate is a first-year MBA at the Stanford Graduate School of Business, where she is a healthcare investor on the Impact Fund and in the Biodesign program.
Prior to Stanford, she worked with the governments of Kenya, Ethiopia, and Uganda to develop and deploy strategies to integrate vaccines into primary health care systems. She spent a year at Gates Ventures developing a global health startup in the areas of nutrition, vaccination, health workforce, and under-5 mortality in partnership with the Gates Foundation. She also spent two years in the McKinsey New York office on the Healthcare Leadership Team, working with clients across the pharmaceutical, payor, provider, and medical device industries.
Kate completed her Bachelor of Science in Bioengineering at Harvard University in 2016.Back To Team